WEC
NPTN

Winslow Evans & Crocker’s NEOPHOTONICS CORP NPTN Stock Holding History

Winslow Evans & Crocker’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1K Hold
120
– – ﹤0.01% 1304
2020
Q3 		$1K Buy
+120
New +$916 ﹤0.01% 1076

Other funds holding NPTN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Winslow Evans & Crocker's NPTN Position: Q4 2020 in Review

Winslow Evans & Crocker held its NEOPHOTONICS CORP (NPTN) position steady in Q4 2020 at 120 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Winslow Evans & Crocker first reported a position in NPTN in Q3 2020 and has held it in 2 quarters since. 138 funds tracked by Wall St. Rank hold NPTN as of Q4 2020.

  • Winslow Evans & Crocker held 120 shares of NEOPHOTONICS CORP worth $1K as of Q4 2020.
  • Winslow Evans & Crocker left its NEOPHOTONICS CORP share count unchanged in Q4 2020.
  • NEOPHOTONICS CORP made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1304 holding.
  • Winslow Evans & Crocker first reported a position in NEOPHOTONICS CORP in Q3 2020 and has held it in 2 quarters since.
  • 138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.